Panopoulou G et al., 2025-02-07: Case series of two patients who developed skin necrosis after methylene blue dye injection for sentinel lymph node mapping during mastectomy and immediate reconstruction. Documents tissue injury from local methylene blue injection.
The first case developed 2 gangrenous areas on the site of the MBD injection. The second one developed skin necrosis as well. The use of MBD is responsible for skin complications, such as skin necrosis.
Panopoulou G et al., 2025-02-07: Case series of two patients who developed skin necrosis after methylene blue dye injection for sentinel lymph node mapping during mastectomy and immediate reconstruction. Documents tissue injury from local methylene blue injection. Study type: case series. N=2. Country: Greece. Methylene blue dye injected subareolar for sentinel node localisation; concentration/volume not in abstract. Funding/conflicts: no financial interest declared. Comparator: none. Bearing CONTRADICTS the "safer than conventional painkillers" claim: local injection can cause gangrene and skin necrosis. Also filed as MTD-089, MTI-80 (claims C12, C16, C7).
